Advertisement

Respiratory Tract Infections and Asthma

  • Ketan K. Sheth
  • William W. Busse

Abstract

For many patients with asthma, especially children, respiratory infections provoke wheezing. Initial attention focused on bacteria as the etiological agents; however, prospective studies conclusively indicated that viral, not bacterial, respiratory infections triggered asthma. Less well established is the possibility that respiratory infections are a pivotal event in the pathogenesis of asthma. This chapter will focus on the role of respiratory tract infections, particularly viral illnesses, and asthma. Three major areas will be covered:
  1. 1.

    The epidemiology of respiratory infections and asthma;

     
  2. 2.

    Respiratory syncytial virus bronchiolitis as a model for respiratory infections and asthma; and

     
  3. 3.

    Mechanisms of virus-induced asthma.

     

Keywords

Respiratory Infection Respiratory Syncytial Virus Airway Smooth Muscle Respiratory Syncytial Virus Infection Respiratory Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Minor TE, Dick EC, DeMeo AN, Ouellette JJ, Cohen M, and Reed CE. Viruses as precipitants of asthmatic attacks in children. JAMA 1974; 227:292–298.PubMedCrossRefGoogle Scholar
  2. 2.
    Henderson FW, Clyde WA, Collier AM, Denny FW, Senior RJ, Shaeffer CI, Conley WG III, and Christian RM. The etiology and epidemiologic spectrum of bronchiolitis in pediatric practice. J. Pediatr. 1979; 95:183–1PubMedCrossRefGoogle Scholar
  3. 3.
    McIntosh K, Ellis EF, Hoffman LS, Lybass TG, Eller JJ, and Fulginiti VA. The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J. Pediatr. 1973; 83:578–5CrossRefGoogle Scholar
  4. 4.
    Horn MEC and Gregg I. Role of viral infection and host factors in acute episodes of asthma and chronic bronchitis. Chest 1973; 63:44–47.CrossRefGoogle Scholar
  5. 5.
    Minor TE, Dick EC, Baker JW, Ouellette JJ, Cohen M, and Reed CE. Rhinovirus and influenza A infections as precipitants of asthma. Am. Rev. Resp. Dis. 1976; 113:149–153.PubMedGoogle Scholar
  6. 6.
    Hudgel DW, Lanston E, Jr, Seiner JC, and Mclntosh K. Viral and bacterial infections in adults with chronic asthma. Am. Rev. Resp. Dis. 1979; 120:393–397.PubMedGoogle Scholar
  7. 7.
    Halperin SA, Eggleston PA, Hendley JO, Suratt PM, Gröschel DHM, and Gwaltney JM, Jr. Pathogenesis of lower respiratory tract symptoms in experimental rhinovirus infection. Am. Rev. Resp. Dis. 1983; 128:806–810.PubMedGoogle Scholar
  8. 8.
    Halperin SA, Eggleston PA, Beasley P, Suratt P, Hendley JO, Gröschel DHM, and Gwaltney JM, Jr. Exacerbations of asthma in adults during experimental rhinovirus infection. Am. Rev. Resp. Dis. 1985; 132:976–980.PubMedGoogle Scholar
  9. 9.
    Berman SZ, Mathison DA, Stevenson DD, Tan EM, and Vaughan JH. Transtracheal aspiration studies in asthmatic patients in relapse with “infective” asthma and in subjects without respiratory disease. J. Allergy Clin. Immunol. 1975; 56:206–214.PubMedCrossRefGoogle Scholar
  10. 10.
    Slavin RG, Cannon RF, Friedman WH, Palitang E, and Sundaram M. Sinusitis and bronchial asthma. J. Allergy Clin. Immunol. 1980; 66:250–254.CrossRefGoogle Scholar
  11. 11.
    Rachelefsky GS, Katz RM, and Siegel SC. Chronic sinus disease associated with reactive airway disease in children. Pediatrics 1984; 73:526–529.PubMedGoogle Scholar
  12. 12.
    Friedman R, Ackerman M, Wald E, Casselbrandt M, Friday G, and Frieman P. Asthma and bacterial sinusitis in children. J. Allergy Clin. Immunol. 1984; 74:185–189.PubMedCrossRefGoogle Scholar
  13. 13.
    Zimmerman B, Stringer D, Feanny S, Resiman J, Hak H, Rashad N, deBenedicts F, McLaughlin J, and Levison H. Prevalence of abnormalities found by sinus x-rays in childhood asthma: lack of relation to severity of asthma. J. Allergy Clin. Immunol. 1987; 80:268–273.PubMedCrossRefGoogle Scholar
  14. 14.
    Tager IB. Epidemiology of respiratory infections in the development of airway hyperreactivity. Sem. Resp. Med. 1990; 11:297–305.CrossRefGoogle Scholar
  15. 15.
    Samet JM, Tager IB, and Speizer FE. The relationship between respiratory illness in childhood and chronic air-flow obstruction in adulthood. Am. Rev. Resp. Dis. 1983; 127:508–523.PubMedGoogle Scholar
  16. 16.
    Eisen AH and Bacal HL. The relationship of acute bronchiolitis to bronchial asthma—a 4-to-14 year follow-up. Pediatrics 1963; 31:859–861.Google Scholar
  17. 17.
    Sporik R, Holgate ST, and Cogswell JJ. Natural history of asthma in childhood—a birth cohort study. Arch. Dis. Child. 1991; 66:1050–10PubMedCrossRefGoogle Scholar
  18. 18.
    Rooney JC and Williams HE. The relationship between proven viral bronchiolitis and subsequent wheezing. J. Pediatr. 1971; 79:744–7PubMedCrossRefGoogle Scholar
  19. 19.
    McConnochie KM and Roghmann KJ. Bronchiolitis as a possible cause of wheezing in childhood. Pediatrics 1984; 74:1–10.PubMedGoogle Scholar
  20. 20.
    Hall CB and McBride JT. Respiratory syncytial virus—from chimps with colds to conundrums and cures. N. Eng. J. Med. 1991; 325:57–58.CrossRefGoogle Scholar
  21. 21.
    Morris JA, Bount RE, and Savage RE. Recovery of cytopathogenic agent from chimpanzees with coryza. Proc. Soc. Exp. Biol. Med. 1956; 92:544–549.PubMedCrossRefGoogle Scholar
  22. 22.
    Chanock R, Roizman B, and Myers R. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA): I: isolation, properties and characterization. Am. J. Hyg. 1957; 66:281–2PubMedGoogle Scholar
  23. 23.
    McConnochie KM, Hall CB, Wash EE, and Roghmann KJ. Variation in severity of respiratory syncytial virus infections with subtype. J. Pediatr. 1990; 117:52–PubMedCrossRefGoogle Scholar
  24. 24.
    Glezen WP, Taber LH, Frank AL, and Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. AJDC 1986; 140:543–566.PubMedGoogle Scholar
  25. 25.
    Monto AS and Lim SK. The Tecumseh study of respiratory illness. III. Incidence and periodicity of respiratory syncytial virus and Mycoplasma Pneumoniae infections. Am. J. Epidemiol. 1971; 94:290–3PubMedGoogle Scholar
  26. 26.
    Hall CB. Respiratory Syncytial Virus, in Textbook of Pediatric Infectious Diseases, 2nd ed., (Feigen RD and Cherry JD, eds.), WB Saunders, Philadelphia, PA, 1987; pp. 1653–1676.Google Scholar
  27. 27.
    Welliver RC. Detection, pathogenesis and therapy of respiratory syncytial virus infections. Clin. Microbiol. Rev. 1988; 1:27–39.PubMedGoogle Scholar
  28. 28.
    McIntosh K, Masters HB, Orr I, Chao RK, and Barkin RM. The immunologic response to infection with respiratory syncytial virus in infants. J. Infect. Dis. 1978; 138:24–32.PubMedCrossRefGoogle Scholar
  29. 29.
    Nadal D and Ogra PL. Development of local immunity: role in mechanisms of protection against or pathogenesis of respiratory syncytial viral infections. Lung 1990; 168(Suppl.):379–387.PubMedCrossRefGoogle Scholar
  30. 30.
    Bienenstock J. Immunology of the Lung and Upper Respiratory Tract. McGraw-Hill, New York, 1984.Google Scholar
  31. 31.
    Faden H, Kaul TN, and Ogra PL. Activation of oxidative and arachidonic acid metabolism in neutrophils by respiratory syncytial virus antibody complexes: possible role in disease. J. Infect. Dis. 1983; 148:110–116.PubMedCrossRefGoogle Scholar
  32. 32.
    Glezen WP, Paredas A, Allison JE, Taber LH, and Frank AL. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group and maternal antibody level. J. Pediatr. 1982; 98:708–7Google Scholar
  33. 33.
    Hemming VG, Rodriguez W, and Kim HW. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob. Agents Chemother. 1987; 31:1882–1886.PubMedCrossRefGoogle Scholar
  34. 34.
    Toms GL, Webb MSC, Milner PD, Milner AD, Routledge EG, Scott R, Stokes GM, Swarbrick A, and Taylor CE. IgG and IgM antibodies to viral glycoprotein in respiratory syncytial viras infections of graded severity. Arch. Dis. Child. 1989; 64:1661–16PubMedCrossRefGoogle Scholar
  35. 35.
    Welliver RC, Wong DT, Sun M, Middleton E, Jr, Vaughan RS, and Ogra PL. The development of respiratory syncytial virus specific IgE and the release of histamine in nasopharyngeal secretions after infection. N. Eng. J. Med. 1981; 305:841–846.CrossRefGoogle Scholar
  36. 36.
    Welliver RC, Wong DT, Sun M, and McCarthy N. Parainfluenza virus bronchiolitis. Epidemiology and pathogenesis. AJDC 1986; 140:34–40.PubMedGoogle Scholar
  37. 37.
    Volovitz B, Welliver RC, DeCastro G, Krystofik DA, and Ogra PL. The release of leukotriene in the respiratory tract during infection with respiratory syncytial viras: Role in obstructive airway disease. Pediatr. Res. 1988; 24:504–507.PubMedCrossRefGoogle Scholar
  38. 38.
    Volovitz B, Faden H, and Ogra PL. Release of leukotriene C4 in respiratory tract during acute viral infection. J. Pediatr. 1988; 112:218–2PubMedCrossRefGoogle Scholar
  39. 39.
    Skoner DP, Fireman P, Caliguiri L, and Davis H. Plasma elevations of histamine and prostaglandin metabolite in acute bronchiolitis. Am. Rev. Resp. Dis. 1990; 142:359–364.PubMedCrossRefGoogle Scholar
  40. 40.
    Welliver RC, Sun M, Rinaldo D, and Ogra PL. Predictive value of respirator syncytial virus-specific IgE response for recurrent wheezing following bronchiolitis. J. Pediatr. 1986; 109:776–7PubMedCrossRefGoogle Scholar
  41. 41.
    Rosner IK, Welliver RC, and Edelson PJ. Effect of Ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infection. J. Infect. Dis. 1987; 155:1043–1046.PubMedCrossRefGoogle Scholar
  42. 42.
    Welliver RC, Kaul TN, Sun M, and Ogra PL. Defective regulation of immune responses in respiratory syncytial virus infection. J. Immunol. 1984; 133:1925–1936.PubMedGoogle Scholar
  43. 43.
    Sims DG, Downham MAPS, and Gardner PS. Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy. Br. Med. J. 1978; 1:14.CrossRefGoogle Scholar
  44. 44.
    Zweiman B, Schoenwetter WF, Pappano JE, Jr, Tempest B, and Hildreth EA. Patterns of allergic respiratory disease in children with a past history of bronchiolitis. J. Allergy 1971; 48:283–286.Google Scholar
  45. 45.
    Pullan CR and Hey EN. Wheezing, asthma, and pulmonary dysfunction 10 year after infection with respiratory syncytial virus in infancy. Br. Med. J. 1982; 284:1665–1669.CrossRefGoogle Scholar
  46. 46.
    Weiss ST, Tager IB, Munoz A, and Speizer FE. The relationship of respiratory infections in early childhood to the occurrence of increased levels of bronchial responsiveness and atopy. Am. Rev. Resp. Dis. 1985; 131:573–578.PubMedGoogle Scholar
  47. 47.
    Sly P and Hibbat M. Childhood asthma following hospitalization with acute viral bronchiolitis in infancy. Pediatr. Pulmonol. 1989; 7:153–1PubMedCrossRefGoogle Scholar
  48. 48.
    Mok JY and Simpson H. Outcome of acute lower respiratory tract infection in infants: preliminary report of seven-year follow-up study. Br. Med. J. 1982; 285:333–337.CrossRefGoogle Scholar
  49. 49.
    Gurwitz D, Mindorff C, and Levison H. Increased incidence of bronchial reactivity in children with a history of bronchiolitis. J. Pediatr. 1981; 98:551–5PubMedCrossRefGoogle Scholar
  50. 50.
    Morgan WJ. Viral respiratory infection in infancy: Provocation or propagation? Sem. Resp. Med. 1990; 11:306–313.CrossRefGoogle Scholar
  51. 51.
    Martinez FD, Morgan WJ, Wright AL, Holberg CI, and Taussig LM. Diminished lung function as a predisposing factor for wheezing respiratory illnesses in infants. N. Eng. J. Med. 1988; 319:1112–1117.CrossRefGoogle Scholar
  52. 52.
    Martinez FD, Morgan WJ, Wright AL, Holberg C, and Taussig LM. Initial airway function is a risk factor for recurrent wheezing respiratory illnesses during the first three years of life. Am. Rev. Resp. Dis. 1991; 143:312–316.PubMedCrossRefGoogle Scholar
  53. 53.
    Stick SM, Arnott J, Turner DJ, Young S, Landau LI, and Lesouëf PN. Bronchial responses and lung function in recurrently wheezing infants. Am. Rev. Resp. Dis. 1991; 144:1012–1015.PubMedCrossRefGoogle Scholar
  54. 54.
    Empey DW, Laitinen LA, Jacobs L, Gold WM, and Nadel JA. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am. Rev. Resp. Dis. 1976; 133:131–139.Google Scholar
  55. 55.
    deJongste JC and Kerrebijn KF. Is bronchial hyperresponsiveness in human a smooth muscle abnormality? Prog. Clin. Biol. Res. 1988; 263:255–265.Google Scholar
  56. 56.
    Fryer AD, El-Fakahany EE, and Jacoby DB. Parainfluenza virus type 1 reduces the affinity of agonists for muscarinic receptors in guinea-pig lung and heart. Eur. J. Pharmacol. 1990; 181:51–PubMedCrossRefGoogle Scholar
  57. 57.
    Laitinen LA, Heino M, Laitinen A, Kava T, and Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am. Rev. Resp. Dis. 1985; 131:599–606.PubMedGoogle Scholar
  58. 58.
    Nadel JA. Role of airway epithelial cells in the defense of airways. Prog. Clin. Biol. Res. 1988; 263:331–339.PubMedGoogle Scholar
  59. 59.
    Saban R, Dick EC, Fishleder RJ, and Buckner CK. Enhancement by parainfluenza 3 infection of contractile responses to substance P and capsaicin in airway smooth muscle from the guinea pig. Am. Rev. Resp. Dis. 1987; 136:586–591.PubMedCrossRefGoogle Scholar
  60. 60.
    Jacoby DB, Tamaoki J, Bornson DB, and Nadel JA. Influenza infection cause airway hyperresponsiveness by decreasing enkephalinase. J. Apply. Physiol. 1988; 64:2653–26Google Scholar
  61. 61.
    Vanhoutte PM. Epithelium-derived relaxing factor(s) and bronchial reactivity. J. Allergy Clin. Immunol. 1989; 83:855–61.PubMedCrossRefGoogle Scholar
  62. 62.
    Butler GB, Adler KB, Evans JN, Morgan DW, and Szarek JL. Modulation of rabbit airway smooth muscle response by respiratory epithelium. Am. Rev. Resp. Dis. 1987; 135:1099–1104.PubMedGoogle Scholar
  63. 63.
    Barnett K, Jacoby DB, Nadel JA, and Lazarus SC. The effects of epithelial cell supernatant on contraction of isolated canine tracheal smooth muscle. Am. Rev. Resp. Dis. 1988; 138:780–783.PubMedCrossRefGoogle Scholar
  64. 64.
    McDonald DM. Respiratory tract infections increase susceptibility to neurogenic inflammation in the rat trachea. Am. Rev. Resp. Dis. 1988; 137:1432–1440.PubMedCrossRefGoogle Scholar
  65. 65.
    Szentivanyi A. The beta-adrenergic theory of atopic abnormality in asthma. J. Allergy 1968; 42:203–223.CrossRefGoogle Scholar
  66. 66.
    Busse WW. Decreased granulocyte response to isoproterenol in asthma during upper respiratory infections. Am. Rev. Resp. Dis. 1977; 115:783–791.PubMedGoogle Scholar
  67. 67.
    Busse WW, Anderson CL, Dick EC, and Warshauer D. Reduced granulocyte response to isoproterenol, histamine, prostaglandin E, after in vitro incubation with rhinovirus 16. Am. Rev. Resp. Dis. 1980; 122:641–646.PubMedGoogle Scholar
  68. 68.
    Roitt IM, Brostoff J, and Male DK. Immunology 2nd ed., Gower Medical Publishing, London, 1989; pp. 19.3–19.6.Google Scholar
  69. 69.
    Lin CY, Kuo YC, Liu WT, and Lin CC. Immunomodulation of influenza virus infection in the precipitating asthma attack. Chest 1988; 93:1234–1238.PubMedCrossRefGoogle Scholar
  70. 70.
    Lemanske RF, Jr, Dick EC, Swenson CA, Vrtis RF, and Busse WW. Rhinovirus upper respiratory infection increases airway reactivity in late asthmatic reactions. J. Clin. Invest. 1989; 83:1–PubMedCrossRefGoogle Scholar
  71. 71.
    Lemanske RF, Jr and Kaliner MA. Late-phase allergic reactions, in Allergy: Principles and Practice (Middleton E, Jr, Reed CE, Ellis EF, Adkinson NF, Jr, and Yunginger JW, eds.), C.V. Mosby, St. Louis, MO, 1988; pp. 224–246.Google Scholar
  72. 72.
    Welliver RC, Wong DT, Middleton E, Jr, Sun M, McCarthy RN, and Ogra PL. Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J. Pediatr. 1982; 101:889–8PubMedCrossRefGoogle Scholar
  73. 73.
    Ida S, Hooks JJ, Siraganian RP, and Notkens AL. Enhancement of IgE-mediate histamine release from human basophil by viruses: Role of interferon. J. Exp. Med. 1979; 145:892–896.CrossRefGoogle Scholar
  74. 74.
    Busse WW, Swenson CA, Borden EC, Treuhauft MW, and Dick EC. The effect of influenza A virus on leukocyte histamine release. J. Allergy Clin. Immunol. 1983; 71:382–388.PubMedCrossRefGoogle Scholar
  75. 75.
    Chonmaitree T, Lett-Brown MA, Tsong Y, Goldman AS, and Baron S. Role of interferon in leukocyte histamine release caused by common respiratory viruses. J. Infect. Dis. 1988; 157:127–132.PubMedCrossRefGoogle Scholar
  76. 76.
    Huftel MA, Swenson CA, Borcherding WR, Dick EC, Hong R, Kita H, Gleich GJ, and Buste WW. The effect of T-cell depletion in enhanced basophil histamine release after in vitro markation with live influenza A virus. Am. J. Respir. Cell Mol. Bio. 1992; 7:434–440.CrossRefGoogle Scholar
  77. 77.
    Naclerio RM, Proud D, Togias AG, Adkinson NF, Jr, Meyers DA, Kagey-Sobotka A, Plaut M, Norman PS, and Lichtenstein LM. Inflammatory mediators in late antigen-induced rhinitis. N. Eng. J. Med. 1985; 313:65–70.CrossRefGoogle Scholar
  78. 78.
    Lett-Brown MA, Aelvoet M, Hooks JJ, Georgiades JA, Thueson DO, and Grant JA. Enhancement of basophil chemotaxis in vitro by virus-induced interferon. J. Clin. Invest. 1981; 67:547–5PubMedCrossRefGoogle Scholar
  79. 79.
    Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, and Kay AB. An ultrastructural, quantitative study and correlation with hyperreactivity. Am. Rev. Resp. Dis. 1989; 140:1745–1753.PubMedCrossRefGoogle Scholar
  80. 80.
    Azzawi M, Bradley B, Jeffery PK, Frew AJ, Wardlaw AJ, Knowles G, Assoufi B, Collins JV, Durham S, and Kay AB. Identification of activated T-lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am. Rev. Resp. Dis. 1990; 142:1407–1413.PubMedCrossRefGoogle Scholar
  81. 81.
    Frew AJ and Kay B. The relationship between infiltrating CD4 lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J. Immunol. 1988; 141:4158–4164.PubMedGoogle Scholar
  82. 82.
    Rothenberg ME, Petersen J, and Stevens RL. IL-5 dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. J. Immunol. 1989; 144:1484–1487.Google Scholar
  83. 83.
    Teale JM and Abraham KM. The regulation of antibody class expression. Immunol. Today 1987; 8:122–126.CrossRefGoogle Scholar
  84. 84.
    White JM and Littman, DR. Viral receptors of the immunoglobulin superfamily cell. Cell 1988; 56:725–728.CrossRefGoogle Scholar
  85. 85.
    Mosmann T, Cherwinski H, Bond M, Giedlin MA, and Coffman RL. Two types of murine helper T-cell clone. J. Immunol. 1986; 136:2348–2357.PubMedGoogle Scholar
  86. 86.
    Kelly EAB, Enderson SC, Hauda KM, and Wassom DL. INF-γ and IL-5 producing cells compartmentalize to different lymphoid organs in Trichinella spiralis-infected mice. J. Immunol. 1991; 147:306–311.PubMedGoogle Scholar
  87. 87.
    Röcken M, Müller KM, Saurat J-H, Müller I, Louis JA, Cerottini J-C, and Hauser C. Central role for TCR/CD3 ligation in the differentiation of CD4+ T-cells toward a Thl or Th2 functional phenotype. J. Immunol. 1992; 148:47–54.PubMedGoogle Scholar
  88. 88.
    Garssen J, Nijkamp FP, Van Der Vliet H, and Van Loveren H. T-cell mediated induction of airway hyperreactivity in mice. Am. Rev. Resp. Dis. 1991; 144:931–938.PubMedCrossRefGoogle Scholar
  89. 89.
    Gazzinelli RT, Makino M, Chattopadhyay SK, Snapper CM, Sher A, Hügin AW, and Morse HC, III. CD4+ subset regulation in viral infection. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J. Immunol. 1992; 148:182–188.PubMedGoogle Scholar
  90. 90.
    Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, and Kay AB. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Eng. J. Med. 1992; 326:298–304.CrossRefGoogle Scholar
  91. 91.
    Bierer BE and Burakoff SJ. T cell adhesion molecules. FASEB J. 1988; 2:2584–2590.PubMedGoogle Scholar
  92. 92.
    Springer TA. Adhesion receptors of the immune system. Nature 1990; 346:425–434.PubMedCrossRefGoogle Scholar
  93. 93.
    Staunton DE, Merluzzi VJ, Rothlein R, Barton R, Marlin SC, and Springer TA. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 1989; 56:849–853.PubMedCrossRefGoogle Scholar
  94. 94.
    Wegner CD, Gundell RM, Reilly P, Haynes N, Letts G, and Rothlein R. Intracellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990; 247:456–459.PubMedCrossRefGoogle Scholar
  95. 95.
    Greve JM, Davis G, Meyer AM, Forte CP, Yost SC, Marlor CW, Kamark ME, and McClelland A. The major human rhinovirus receptor is ICAM-1. Cell 1989; 56:839–847.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Ketan K. Sheth
    • 1
  • William W. Busse
    • 1
  1. 1.University of Wisconsin Medical SchoolMadisonUSA

Personalised recommendations